|
Randomized Phase II Study of Clofarabine or Fludarabine Combined with Idarubicin and Cytarabine for the Treatment of Newly Diagnosed AML |
|
|
|
Title: |
Randomized Phase II Study of Clofarabine or Fludarabine Combined with Idarubicin and Cytarabine for the Treatment of Newly Diagnosed AML |
Author: |
Yilmaz, Musa Sasaki, Koji Ravandi, Farhad Cortes, Jorge Garcia-Manero, Guillermo Kadia, Tapan Daver, Naval Pemmaraju, Naveen Borthakur, Gautam Dinardo, Courtney Takahashi, Koichi O’Brien, Susan Estrov, Zeev Pike, Allison Brandt, Mark Kantarjian, Hagop Jabbour, Elias |
Appeared in: |
Clinical lymphoma myeloma and leukemia |
Paging: |
Volume 15 (2015) nr. S2 pages 1 p. |
Year: |
2015 |
Contents: |
|
Publisher: |
Published by Elsevier B.V. |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|